Drug delivery business Avectas has licensed a therapy from Galway-based ONK Therapeutics that targets what are called B-cell malignancies – blood cell cancers such as non-Hodgkin’s lymphoma (above)

Two cutting edge Irish pharmaceutical companies have announced a deal that they hope will deliver significantly improved treatment for people with cer(...)